Bone Biologics (BBLGW) Retained Earnings (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Retained Earnings for 2 consecutive years, with $56.4 million as the latest value for Q3 2017.
- Quarterly Retained Earnings rose 18.93% to $56.4 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $56.4 million through Sep 2017, up 18.93% year-over-year, with the annual reading at -$52.1 million for FY2016, N/A changed from the prior year.
- Retained Earnings for Q3 2017 was $56.4 million at Bone Biologics, up from $54.0 million in the prior quarter.
- The five-year high for Retained Earnings was $56.4 million in Q3 2017, with the low at -$52.1 million in Q4 2016.